Pharma and Healthcare

Biocon has announced that it is to fully integrate Biocon Biologics Limited

Biocon to leverage global USP with biologics merger: Kiran Mazumdar-Shaw

Biocon Limited (which holds around 78 per cent) will acquire the remaining stake in Biocon Biologics through a share swap…

Updated: December 6, 2025 15:55 IST

100 million Indians could be on GLP-1 drugs by 2030: Healthify CEO

” We are doing $1-2 million run rate revenue in the US. We expect the US business to be larger…

Updated: December 3, 2025 22:36 IST

Eli Lilly market cap, Eli Lilly trillion dollar, Zepbound Mounjaro sales, obesity drug market, tirzepatide Eli Lilly, weight loss drugs US, Ozempic vs Mounjaro, Wegovy vs Zepbound, Eli Lilly stock surge, obesity drug industry, Business, Eli Lilly and Co, Health care industry, Pharmaceuticals, Biotech and Pharmaceuticals, Biotechnology, Business, Berkshire Hathaway Inc, Novo Nordisk A/S, UnitedHealth Group Inc, Berkshire Hathaway Inc, NVIDIA Corp, Meta Platforms Inc, Amazon.com Inc, Alphabet Class A, Microsoft Corp, Apple Inc, Novo Nordisk A/S, business news

Eli Lilly becomes first pharma company to hit $1 trillion market-cap

Wall Street projects the global weight-loss drug market could reach $150 billion by 2030, with Lilly and Novo Nordisk expected…

November 21, 2025 21:22 IST

The Trump effect: How Indian pharma’s ‘beyond US’ bet is finally paying off

Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs on…

November 11, 2025 05:30 IST

Are these 3 pharma companies the market’s best-kept secret? Their numbers say yes.

Three pharma companies that have delivered the highest average 5-year ROCE are all into manufacturing the same type of products.…

November 2, 2025 08:32 IST

Roche vs Natco: Delhi HC dismisses Roche's plea

Delhi HC dismisses Swiss pharma giant’s injunction plea: All we know

After months of hearings, the Delhi High Court delivered the landmark ruling which cleared the way for Natco Pharma to…

Updated: October 10, 2025 11:35 IST

India's Revised PRIP Scheme: A Boost for Pharma R&D or Still Falling Short of Novel Drug Dreams?

New pharma R&D scheme helpful only for incremental products: Experts

Industry experts debate if the revised Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme, with a Rs 5,000 crore…

October 5, 2025 18:04 IST

Roche Pharma Commits $1.9 Billion Investment in India Over 5 Years.

Roche commits $1.9 bn investment in India over next 5 yrs

Swiss healthcare giant Roche Pharma announced a major expansion, committing 1.5 billion Swiss francs ($1.9 billion) investment in India over…

October 2, 2025 05:15 IST

Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV

Lupin buys Amsterdam-based VISUfarma for Euro 190 million to boost speciality eye care portfolio

Lupin to acquire VISUfarma for €190 million, enhancing its European presence and ophthalmology portfolio with over 60 eye health products.

September 29, 2025 10:43 IST

ICICI Lombard Dividend 2025: Check record date, eligibility, and other key details

Dividend stocks: Glenmark Pharma only stock to trade ex-dividend this week

Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…

September 28, 2025 07:00 IST

Pharma Stocks Slump on US 100% Tariff News, But Experts Say Generic Exports are Safe.

Pharma stocks fall on 100% US tariff on branded drugs; no immediate impact, but threat to generics stays

Indian pharma stocks fell up to 7% in reaction to the US imposing a 100% tariff on imported branded and…

September 26, 2025 19:44 IST

Nifty Pharma index today, Nifty Pharma down, Indian pharma stocks fall

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…

September 26, 2025 11:50 IST

Natco Pharma is going to demerge its agro business from the core pharmaceutical business.

Natco Pharma demerger plan approved by board: What it means for agro and core pharma business

Natco Pharma plans to demerge its agro business from core pharma to unlock value, enhance focus, and ensure dedicated management.

September 25, 2025 12:05 IST

Scheme to boost innovation in pharma sector soon, says DoP secretary

The scheme, announced in August 2023, is aimed at fostering innovation in the pharmaceutical and medical devices sectors, with a total financial…

September 17, 2025 08:23 IST

Re-labelling not mandatory; GST benefits on medicines from Sept 22

Govt says relabelling for medicine packs not mandatory, manufacturers must issue a revised price list

Government clarifies re-labelling of medicines is not mandatory as new GST rates take effect from September 22.

Updated: September 16, 2025 16:33 IST

Zydus launches India’s first trivalent influenza vaccine VaxiFlu for seasonal flu protection

Zydus Lifesciences has launched VaxiFlu, India’s first trivalent influenza vaccine for seasonal flu protection. The vaccine follows WHO’s 2025–26 guidelines…

September 2, 2025 15:41 IST

Explainer: Why data exclusivity in pharma could be risky

Allowing data exclusivity would prevent the drug regulator — Central Drugs Standard Control Organisation — from granting marketing approval for…

Updated: August 26, 2025 15:59 IST

Trump’s tariff threats are spooking pharma. Are MNC stocks the answer?

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…

August 19, 2025 15:49 IST

Related News

Meta CEO Mark Zuckerberg’s highest-paid employee Alexandr Wang tells teens how to build a lucrative tech future

Vibe Coding at Meta: How product managers are rapidly building prototype apps for Facebook's Mark Zuckerberg

Vibe Coding at Meta: How product managers are quickly building prototype apps for Facebook’s Mark Zuckerberg

Green card holders, US citizenship, naturalized citizens, naturalization process, denaturalization

Green card holders turned US citizens face new denaturalization threat under Trump

OPT program, OPT program end, Optional Practical Training program ended, F-1 visas, H-1B visas, Fairness for High-Skilled Americans Act

Fairness for High-Skilled Americans Act introduced to terminate ‘dangerously unauthorized’ OPT program

PMI Electro Dominates India’s Largest E-Bus Tender

Centre wraps up mega e-bus tender; PMI bags half of 10,900 buses

From fringe to mainstream

Technology3 hr ago

India is making significant progress in its AI journey, with strong digital infrastructure and a growing market. The government’s investment in AI development reflects their determination to become a leader in this field. Collaboration between technology providers, enterprises, and the public sector is crucial for unleashing the full potential of AI.

View all shorts